Tech Company Financing Transactions
Twist Bioscience Funding Round
Twist Bioscience closed a $27 million funding round on 6/15/2017. Investors included Bay City Capital, Biomatics Capital Partners and Reinet Investments.
Transaction Overview
Company Name
Announced On
6/15/2017
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Undisclosed
Proceeds Purpose
Twist Bioscience expects to use the funding to facilitate increased growth in the company's core business of gene synthesis and increased investment into two vertical market segments of drug discovery and DNA digital data storage.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
455 Mission Bay Blvd South
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Undisclosed
Website
Email Address
Overview
At Twist Bioscience (Nasdaq: TWST), our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emily Leproust
Chief Financial Officer
Solange Glaize
Chief Operating Officer
Bill Banyai
Chief Technical Officer
Bill Peck
VP - Operations
Patrick Weiss
VP - Sales
Patrick Finn
Browse more venture capital transactions:
Prev: 6/15/2017: Shadow venture capital transaction
Next: 6/15/2017: Bowery Farming venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs